Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PRVB | VERA | VCEL | ||
Company | Provention Bio Inc | Vera Therapeutics Inc Cl A | Vericel Corporation | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 24.99 | 44.96 | 48.87 | ||
High | 25.00 | 45.48 | 49.00 | ||
Low | 24.98 | 43.40 | 47.56 | ||
Last | 24.98 | 43.44 | 47.83 | ||
Change | +0.75 | -0.06 | -0.05 | ||
% Change | +3.10% | -0.14% | -0.10% | ||
Volume | 9,124,100 | 582,109 | 345,261 | ||
20-Day Average Volume | 2,505,925 | 1,289,246 | 318,768 | ||
Previous Close | 24.23 | 43.50 | 47.88 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 24.34 | 41.44 | 47.06 | ||
20-Day Raw Stochastic | 98.15% | 51.74% | 59.85% | ||
20-Day Relative Strength | 79.66% | 54.34% | 52.91% | ||
Weighted Alpha | +19.60 | +87.44 | +49.37 | ||
Today's Opinion | 100% Buy | 80% Buy | 72% Buy | ||
Previous Opinion | 88% Buy | 80% Buy | 88% Buy | ||
Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +2.21% since 04/19/23 | +9.74% since 04/26/24 | +3.80% since 04/26/24 | ||
Low | 24.20 on 04/25/23 | 38.85 on 04/30/24 | 45.46 on 05/01/24 | ||
High | 25.00 on 04/26/23 | 45.48 on 05/03/24 | 49.00 on 05/03/24 | ||
1-Month | |||||
%Chg | +4.56% since 03/24/23 | +9.87% since 04/03/24 | -6.88% since 04/03/24 | ||
Low | 23.82 on 03/27/23 | 35.85 on 04/10/24 | 42.38 on 04/19/24 | ||
High | 25.00 on 04/26/23 | 50.65 on 04/12/24 | 51.84 on 04/04/24 | ||
3-Month | |||||
%Chg | +186.80% since 01/26/23 | +11.14% since 02/02/24 | +11.45% since 02/02/24 | ||
Low | 6.59 on 03/10/23 | 35.85 on 04/10/24 | 41.58 on 02/07/24 | ||
High | 25.00 on 04/26/23 | 50.78 on 03/01/24 | 53.05 on 04/01/24 | ||
6-Month | |||||
%Chg | +279.64% since 10/26/22 | +313.59% since 11/03/23 | +29.68% since 11/03/23 | ||
Low | 6.38 on 10/28/22 | 9.88 on 11/06/23 | 32.28 on 11/09/23 | ||
High | 25.00 on 04/26/23 | 50.78 on 03/01/24 | 53.05 on 04/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,367,629 | 2,368,662 | 2,316,435 | ||
Shares Outstanding, K | 94,781 | 54,452 | 48,380 | ||
Annual Sales | 12,900,000 | 0 | 197,520,000 | ||
Annual Net Income | -113,570,000 | -95,990,000 | -3,180,000 | ||
Last Quarter Sales | 10,810,000 | 0 | 65,000,000 | ||
Last Quarter Net Income | -33,280,000 | -25,650,000 | 12,990,000 | ||
60-Month Beta | 2.47 | 1.11 | 1.74 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.38 on 03/29/23 | -0.58 on 03/20/24 | 0.26 on 02/29/24 | ||
Latest Earnings Date | 05/04/23 | 05/09/24 | 05/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |